On our screens:Stocks with no debt
Is the price fair?
What HWKN's price assumes
Hawkins, Inc. trades at 32.4× earnings against 27.9× for the median Specialty Chemicals name, more expensive than its own group.
32.4
Trailing P/E · Specialty Chemicals median 27.9 · 1.16× the median: the market pays up for this one
- Price / sales
- 2.91
Price / sales · as of 2026-Q1
- Free cash flow yield
- 2.5%
Free cash flow yield · Specialty Chemicals median 3.9%
- Growth the price implies
- +15%
Growth the price implies · The price pays for +15% free cash flow growth a year for a decade; the business has delivered +44% a year over the last three.
Details›
- Price / book2026-Q1
- 5.90
- EV / EBIT2026-Q1
- 28.0
- EV / sales2026-Q1
- 3.13
- Basic Materials median P/E159 names
- 22.3
- Specialty Chemicals median P/E37 names
- 27.9
- Free cash flow, trailing twelve months
- $86M
- Market capitalisation
- $3.46B
- 3-year revenue growth
- +5.0%
- 3-year free cash flow growth
- +44%
| Method | Per share |
|---|---|
| What its own history would imply | not meaningful, 38.9× today against a 14.9× median |
| 52-week range | $117.89 – $182.85 |
| Today | $126.78 |
Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.
Specialty Chemicals
Ranks #25 of 27 by Smart Score